ImmunoCreate Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $50K

  • Investors
  • 1

ImmunoCreate General Information

Description

Developer of a Beta-actin monoclonal antibody designed for the diagnosis and treatment of neurofibromatosis. The company is currently operating in Stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 100 Oxmoor Road
  • Suite 110
  • Birmingham, AL 35209
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Delivery
Drug Discovery
Vertical(s)
Corporate Office
  • 100 Oxmoor Road
  • Suite 110
  • Birmingham, AL 35209
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoCreate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Oct-2024 $50K Completed Stealth
To view ImmunoCreate’s complete valuation and funding history, request access »

ImmunoCreate Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Depot Accelerator/Incubator Minority
To view ImmunoCreate’s complete investors history, request access »

ImmunoCreate FAQs

  • When was ImmunoCreate founded?

    ImmunoCreate was founded in 2012.

  • Where is ImmunoCreate headquartered?

    ImmunoCreate is headquartered in Birmingham, AL.

  • What industry is ImmunoCreate in?

    ImmunoCreate’s primary industry is Pharmaceuticals.

  • Is ImmunoCreate a private or public company?

    ImmunoCreate is a Private company.

  • What is the current valuation of ImmunoCreate?

    The current valuation of ImmunoCreate is .

  • What is ImmunoCreate’s current revenue?

    The current revenue for ImmunoCreate is .

  • How much funding has ImmunoCreate raised over time?

    ImmunoCreate has raised $50K.

  • Who are ImmunoCreate’s investors?

    Innovation Depot has invested in ImmunoCreate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process